Context Therapeutics (CNTX) Total Debt (2020)
Context Therapeutics (CNTX) posted Total Debt of $5.9 million for Q4 2020.
Context Therapeutics (CNTX) Total Debt (2020) Analysis & Trends
Context Therapeutics has reported Total Debt for 1 years, with the latest figure at $5.9 million in Q4 2020.
- Quarterly Total Debt changed N/A year-over-year to $5.9 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $5.9 million (changed N/A YoY) and the FY2020 annual result came in at $5.9 million, changed N/A from the prior year.
- Total Debt held at $5.9 million in Q4 2020 per CNTX's latest filing.
- Over five years, Total Debt peaked at $5.9 million in Q4 2020 and troughed at $5.9 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.34 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 770.36 Mn |
| 10 | Context Therapeutics | 49.23 Mn | 49.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 5.90 Mn |